Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.
about
Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoterPlasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells.Plasminogen activator inhibitor-1 and the kidney.PAI-1 and atherothrombosis.Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-betaRegulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.cDNA cloning of human plasminogen activator-inhibitor from endothelial cellsSecretory products of macrophages.The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expressionAntilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells.Impact of endothelial activation on fibrinolysis and local proteolysis in tissue repair.Possibilities of DNA analysis for the detection of predisposition to thrombotic disease.Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.Pathophysiologic effect of interleukin-1b in the rabbit retina.Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissueAmerican Association of Pathologists president's address. New roles for the endothelium in inflammation and immunityAcute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cellsDecreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantationImmunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.Immunohistochemical study of vascular injury in acute multiple sclerosis.Assessment of endothelial dysfunction.Procoagulant activity in gastroenterology.The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family.Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC.Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.Transforming growth factors in the regulation of malignant cell growth and invasion.New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.Interleukin-1: therapeutic potential for solid tumors.Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro.1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.Effects of tumour necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells.Fibrinolysis in LPS-induced chronic airway disease.Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes.
P2860
Q33635406-514B8B88-C1C1-4B99-BA51-A96FB0C36D24Q33812093-CEF3EB3F-1819-4D4D-999B-BA62D49698A9Q33899837-F538BF56-B990-4FF3-B3BC-9932992488C8Q33929407-33823E6C-A69C-43E7-8585-68C489ED5AC0Q33960082-89F00154-5A0D-424B-971B-4471A555C9FDQ33989347-78AF2EE0-9FBD-413D-8CA5-9305B3A9899DQ34205401-85D53C89-757F-4B06-AF4E-C8BECA1EC820Q34534987-CC2DF5A8-A5E2-4477-8FD2-51F54E97EE17Q34551601-F60090F2-58E1-4B52-A396-3F00F3B5435AQ34557411-EDE144A8-90EB-485D-B714-029259ECF3B0Q34559926-9D4631BB-2115-4845-8B53-3806686A529CQ35096235-4032D013-39D5-4C10-9132-D878E01B0637Q35172771-79A6D6D3-D734-43B9-BC83-96FF6482A025Q35224536-78E96585-DC7B-49D4-A45E-C3C83A7CD31CQ35580262-C644FF8E-CFCA-4484-BE04-3F4B46B8124AQ35812152-7C6DE01F-B058-4A87-ADCD-9E5971FCC917Q35832540-0B3D4736-D9FA-4EEE-9C6B-73F09BD74316Q35856528-2F6CE72E-B8E6-44D8-BB87-48A8DF78E433Q35856557-3C363572-DEB6-4D60-91EB-7CD5A0FD4788Q36352574-F1E5D132-D59E-4FE8-AB52-D03D3572339DQ36353173-AD9C2537-3C0C-46F4-B8A9-E4B5E7EAD319Q36353693-C25BF519-6B16-4941-B571-82E547BDF754Q36438240-36AA36C2-29E9-43E8-AE38-19B62FBEFDB7Q36529883-8DDBD4C2-FFA4-44EB-AF30-3A0E50661AC6Q37246358-399D0094-6DE2-4A8B-AB33-B9D374BA338DQ37732250-1E9B417A-F737-48BD-8261-E264FA1DA571Q37905882-449104FD-8B90-44EB-A618-98B7A32F2913Q38346314-E4D98F44-ACCA-4E58-8592-CEC7E522F3F6Q38894933-63822EC0-0A4C-4610-90D9-D535315B5AB8Q39561337-80223292-BC8E-48F3-87A2-76217C655EF2Q39573228-5FFB6FB6-9D61-47A2-8CDA-F6C709E6CB8EQ40771484-E1D59486-3766-40A7-A698-011F27AC1F8DQ40860960-4F1012F5-BE23-4407-A3C8-6BBA1C46E173Q41861489-4A3535FA-DF1B-452C-875D-34DC88528361Q41872361-824AD03B-0050-472D-B2A2-589E7FB44B67Q42431521-165A79DF-ACF1-4F3A-A232-68C3DD0BA5FEQ42738197-AB8E3169-954B-44BA-9FC2-8C7E014ECD0BQ43861741-6C984C33-5D94-4D70-BAE1-A2EE856F8B4CQ44486005-48125159-03CF-40D0-BAC8-5DB2D3BB320EQ44758262-28B27CF8-1F6C-4AB5-AFE2-FBADC7B84B4B
P2860
Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Interleukin 1 and lipopolysacc ...... in cultured endothelial cells.
@en
type
label
Interleukin 1 and lipopolysacc ...... in cultured endothelial cells.
@en
prefLabel
Interleukin 1 and lipopolysacc ...... in cultured endothelial cells.
@en
P2860
P356
P1476
Interleukin 1 and lipopolysacc ...... in cultured endothelial cells.
@en
P2093
P2860
P304
P356
10.1084/JEM.163.5.1260
P407
P577
1986-05-01T00:00:00Z